Boston Scientific stock costs EUR 38.37, volume is 7.4 percent of average

Published on 10/12/2026 at 16:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Boston Scientific stock stands at EUR 38.37 on October 12, 2026. Volume is 7.40 percent of average at 1,470,588 shares for the session.

Key points in brief

Boston Scientific stock was at EUR 38.37 at Lang & Schwarz on October 12, 2026 at 4:37 p.m. CEST.
Volume was 1,470,588 shares against an average of 19,888,529 shares.
The NYSE quote was USD 42.95, while the 52-week range was USD 41.39 to USD 105.65.
MarketBeat listed 22 Buy, 6 Hold and 2 Sell ratings, with an average target of USD 66.31.
Boston Scientific reported USD 5.44 billion in second-quarter 2026 sales, up 7.50 percent year over year.

Isometrisches 3D-Diagramm der REIT-Wertschöpfungskette mit Bürogebäude, Mietern und Investoren — Boston Properties US1011371077 visualisiert die Immobilien-REIT-Wertschöpfungskette isometrisch mit Mietern, Investoren und Verwaltern, Illustration mit AI erstellt.

Boston Scientific stock was at EUR 38.37 at Lang & Schwarz on October 12, 2026 at 4:37 p.m. CEST. The session volume was 1,470,588 shares against an average of 19,888,529, equal to 7.40 percent of the average.

Intraday quote and home listing

The Lang & Schwarz quote places the German-market euro price below the latest US listing value. Boston Scientific traded at USD 42.95 on the NYSE on October 12, 2026, with a market capitalization of USD 63.8 billion and a price-to-earnings ratio of 17.5.

The US listing is clearly assigned to Boston Scientific under ticker BSX and ISIN US1011371077 by Global Banking and Finance. The company operates in medical devices, spanning interventional specialties and organized around MedSurg, Rhythm and Neuro, and Cardiovascular activities.

Range spans USD 41.39 to USD 105.65

Boston Scientific's 52-week range on the NYSE was USD 41.39 to USD 105.65 on October 12, 2026. The current USD 42.95 quote therefore sits USD 1.56 above the yearly low, while the euro quote and the US quote remain separate measures from different venues.

Valuation and next earnings date

MarketBeat listed 30 analyst ratings, including 22 Buys, 6 Holds and 2 Sells, with an average twelve-month target of USD 66.31 on October 11, 2026. Its consensus rating was Moderate Buy. The target is a separate US-dollar valuation reference, not a conversion of the EUR 38.37 Lang & Schwarz quote.

Boston Scientific reported USD 5.44 billion in net sales in the second quarter of 2026, up 7.50 percent on a reported basis from the prior-year quarter, according to PR Newswire. The next earnings date is October 28, 2026, as listed by Yahoo Finance.

Comparison with peers

Boston Scientific: P/E 17.5, market capitalization USD 63.8 billion
Medtronic (NYSE, USD): plus 3.07 percent, P/E 22.5, market capitalization USD 116.7 billion
Edwards Lifesciences (NYSE, USD): plus 0.13 percent, P/E 49.0, market capitalization USD 49.1 billion

Euro price at Lang & Schwarz

The reference quote was EUR 38.37 at Lang & Schwarz on October 12, 2026 at 4:37 p.m. CEST. The continuously updated quote remains useful for comparing the euro-market indication with the NYSE listing and the dated valuation figures above. The further course of trading is shown by the continuously updated real-time quote of Boston Scientific stock.